Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-277-2 | CAS number: 1119-40-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study was done according to OECD 474 with no listed deviations, and the test substance is adequately defined
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Dimethyl glutarate
- EC Number:
- 214-277-2
- EC Name:
- Dimethyl glutarate
- Cas Number:
- 1119-40-0
- Molecular formula:
- C7H12O4
- IUPAC Name:
- 1,5-dimethyl pentanedioate
- Details on test material:
- Clear liquid
99.61% pure
Batch Number: H931363-A
Supplier: DuPont
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female animals weighed between 152.1-173.6 grams and 125.7 and 148.6 grams, respectively. Animals were randomly assigned to groups with sexes separated. Groups, n=5/sex/exposure group, were kept in cages with a controlled environment. The temperature was kept at 21°C with a relative humidity of 50%. The room was illumiated for 12 hours per day. Animals were provided food and tap water ad libitum except when it was witheld prior to exposure. Aniamls were acclimatized to at least 12 days prior to study initiation.
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Vehicle:
- None
- Details on exposure:
- Liquid test material was delivered to a concentric jet atomiser and generated as droplets into a stream of dry air for administraion to the rats in whole body exposure chambers. Exposure concentration was achieved by meteringthe test substance from polypropylene syringes mounted on syringe drivers.
Exposures were:
0 mg/L (Air) - Negative control
0.5 mg/L (0.545 analytical)
1.0 mg/L (0.807 anayltical)
2.0 mg/L (2.298 analytical)
20 mg/kg Cyclophosphamide (positive control) - Duration of treatment / exposure:
- 6 hours/day
- Frequency of treatment:
- 2 days
- Post exposure period:
- 24 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Basis:
analytical conc.
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- yes
- Positive control(s):
- Cyclophosphamide 20 mg/kg adminstered by oral gavage at the end of the second exposure treatment
Examinations
- Tissues and cell types examined:
- Femoral bone marrow
- Details of tissue and slide preparation:
- Following sacrifice of animals, Both femurs of each animal were removed and bone marrow extracted and pooled into 10 mL of salt solution. The cell suspensions were centrifuged at 1000g for 5 minutes. The pellet was resuspended in 2 ml of filtered fetal calf serum to facilitate smearing on glass slides. Several smears were prepared from each femur. A modified Feulgen staining method was used which stains DNA-containing bodies deep purple without staining mast cell granules. The method also allows for differentiation of mature and immature erythrocytes.
- Evaluation criteria:
- Slides were examined by light microscopy to determine the incidence of micronucleated cells per 2000 polychromatic erythrocytes. Micronuclei were identified with the following criteria:
- large enough to discern morphological characteristics
-should be generally rounded in shape with clearly defined outline
-should be deeply stained and in color similar to other nuclei
-should lie in the same focal plane as the cell
-lack internal structure
-there should be no micronulceus like debris surrounding the cell
A portion of immature erythrocytes for each animal was asessed by examination of at least 1000 erythrocytes.
A positive repsonse is normally indicated by a statistically significant dose-related increase in the incidence of micronucleated immature erythrocytes for the treatment group compared to controls (p<0.01) and exceed laboratory historical control ranges.
Bone marrow cell toxicity is indicated by a substantial and statistically significant dose-related decrease in the proportion of immature erythrocytes (p < 0.01).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- lethargy, piloerection, partially closed eyes, brown staining
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Treatment |
Exposure level |
Percent Immature Erythrocytes |
Number of micronucleated cells per 2000 Immature Erythrocytes |
Number of micronucleated cells per 2000 Mature Erythrocytes |
Negative control |
0 |
31 |
0.1 |
0.6 |
Dimethyl glutarate |
0.5 mg/L |
32 |
0.4 |
0.0 |
|
1.0 mg/L |
31 |
0.4 |
0.3 |
|
2.0 mg/L |
32 |
0.2 |
0.6 |
Cyclophosphamide |
20 mg/kg |
27 |
5.9 (p<0.001) |
0.0 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Dimethyl glutarate does not show any evidence of causing chromosomal damage or bone marrow cell toxicity when administered by whole body inhalation exposure. - Executive summary:
Dimethyl glutarate was administered to F344 rats by whole body inhalation to measure the potential to form micronuclei in bone marrow. Animals were exposed to 0, 0.5. 1.0 and 2.0 mg/l ( analyzed as 0, 0.545, 0.807, and 2.298 mg/L) for 6 hours per day for 2 consecutive days. A positive control group received 20 mg/kg of cyclophophamide by gastric intubation. The were some incidence of weight loss but not considered significant as well as clinical sign (lethargy, partially closed eyes, piloerection, smacking mouth, brown staining of snout and jaws, and oily fur).
Bone marrow smears were obtained 24 hours after exposure from treated and control animals. Smears were were evaluated for the presence of micronuclei in 2000 immature erythrocytes. The proportion of immature erythrocytes was assessed by examination of at least 1000 erythrocytes.
No statistically significant increases in the frequency of micronucleated immature erythrocytes and no substantial decrease in the proportion of immature erythrocytes were observe in dimethyl glutarate-treated animals.
Dimethyl glutarate does not show any evidence of causing chromosomal damage or bone marrow cell toxicity when administered by whole body inhalation exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.